BIMI
Income statement / Annual
Last year (2022), BIMI International Medical Inc.'s total revenue was $11.83 M,
a decrease of 44.51% from the previous year.
In 2022, BIMI International Medical Inc.'s net income was -$22.39 M.
See BIMI International Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$11.83 M |
$21.32 M |
$12.85 M |
$157.98 K |
$6.54 M |
$8.51 M |
$6.04 M |
$6.72 M |
$9.98 M |
$5.68 M |
| Cost of Revenue |
$9.88 M
|
$18.89 M
|
$10.40 M
|
$304.12 K
|
$6.08 M
|
$7.59 M
|
$5.89 M
|
$5.54 M
|
$8.50 M
|
$4.13 M
|
| Gross Profit |
$1.95 M
|
$2.43 M
|
$2.44 M
|
-$146.00 K
|
$459.35 K
|
$916.51 K
|
$148.77 K
|
$1.18 M
|
$1.48 M
|
$1.54 M
|
| Gross Profit Ratio |
0.16
|
0.11
|
0.19
|
-0.92
|
0.07
|
0.11
|
0.02
|
0.18
|
0.15
|
0.27
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$56.19 K
|
$73.24 K
|
$96.57 K
|
$105.17 K
|
$107.87 K
|
$79.45 K
|
| General & Administrative Expenses |
$10.60 M
|
$6.06 M
|
$5.47 M
|
$985.97 K
|
$16.12 M
|
$2.05 M
|
$1.59 M
|
$1.72 M
|
$1.83 M
|
$1.06 M
|
| Selling & Marketing Expenses |
$1.30 M
|
$2.15 M
|
$783.13 K
|
$0.00
|
$133.79 K
|
$63.45 K
|
$35.82 K
|
$100.38 K
|
$32.78 K
|
$98.86 K
|
| Selling, General & Administrative Expenses |
$11.90 M
|
$8.21 M
|
$6.26 M
|
$985.97 K
|
$16.25 M
|
$2.11 M
|
$1.63 M
|
$1.82 M
|
$1.86 M
|
$1.16 M
|
| Other Expenses |
$5.39 M
|
$0.00
|
$0.00
|
$581.03 K
|
-$56.19 K
|
-$26.86 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$17.29 M
|
$8.21 M
|
$6.26 M
|
$1.57 M
|
$16.25 M
|
$2.11 M
|
$1.63 M
|
$1.82 M
|
$1.68 M
|
$1.16 M
|
| Cost And Expenses |
$27.17 M
|
$27.10 M
|
$16.66 M
|
$1.87 M
|
$22.34 M
|
$9.70 M
|
$7.52 M
|
$7.36 M
|
$10.36 M
|
$5.29 M
|
| Interest Income |
$0.00
|
$3.10 K
|
$304.00
|
$0.00
|
$505.00
|
$0.00
|
$14.25 K
|
$11.79 K
|
$63.15 K
|
$36.69 K
|
| Interest Expense |
$3.43 M
|
$2.44 M
|
$84.91 K
|
$6.35 K
|
$416.41 K
|
$353.75 K
|
$354.42 K
|
$398.64 K
|
$420.94 K
|
$592.53 K
|
| Depreciation & Amortization |
$223.56 K
|
$244.12 K
|
$56.04 K
|
$261.98 K
|
$1.04 M
|
$944.01 K
|
$998.19 K
|
$1.27 M
|
$844.66 K
|
$831.08 K
|
| EBITDA |
-$17.97 M |
-$31.98 M |
-$3.21 M |
-$1.27 M |
-$15.54 M |
-$278.00 K |
-$465.00 K |
$662.72 K |
$713.17 K |
$1.29 M |
| EBITDA Ratio |
-1.52
|
-1.5
|
-0.25
|
-8.03
|
-2.38
|
-0.03
|
-0.08
|
0.1
|
0.07
|
0.23
|
| Operating Income Ratio |
-1.3
|
-0.38
|
-0.3
|
-6.24
|
-2.41
|
-0.14
|
-0.24
|
-0.1
|
-0.04
|
0.07
|
| Total Other Income/Expenses Net |
-$6.28 M
|
-$26.56 M
|
$460.55 K
|
-$550.00 K
|
-$790.00 K
|
-$381.00 K
|
-$337.00 K
|
-$369.00 K
|
-$176.00 K
|
-$519.00 K
|
| Income Before Tax |
-$21.62 M
|
-$34.66 M
|
-$3.35 M
|
-$1.54 M
|
-$16.78 M
|
-$1.58 M
|
-$1.82 M
|
-$1.01 M
|
-$552.00 K
|
-$133.00 K
|
| Income Before Tax Ratio |
-1.83
|
-1.63
|
-0.26
|
-9.72
|
-2.57
|
-0.19
|
-0.3
|
-0.15
|
-0.06
|
-0.02
|
| Income Tax Expense |
$6.09 K
|
$29.67 K
|
$434.31 K
|
$0.00
|
$117.00
|
$2.74 K
|
$246.00
|
-$40.30 K
|
$64.86 K
|
$47.02 K
|
| Net Income |
-$22.39 M
|
-$34.99 M
|
-$5.29 M
|
-$4.44 M
|
-$16.79 M
|
-$1.57 M
|
-$1.82 M
|
-$969.00 K
|
-$617.00 K
|
-$180.00 K
|
| Net Income Ratio |
-1.89
|
-1.64
|
-0.41
|
-28.1
|
-2.57
|
-0.18
|
-0.3
|
-0.14
|
-0.06
|
-0.03
|
| EPS |
-8.4 |
-65.1 |
-24.8 |
-27.5 |
-112.25 |
-11.1 |
-14 |
-7.74 |
-5.5 |
-1.64 |
| EPS Diluted |
-8.4 |
-65.1 |
-24.8 |
-27.5 |
-112.25 |
-11.1 |
-14 |
-7.74 |
-5.5 |
-1.64 |
| Weighted Average Shares Out |
$2.67 M
|
$536.29 K
|
$213.46 K
|
$163.38 K
|
$149.55 K
|
$141.47 K
|
$129.83 K
|
$125.31 K
|
$112.23 K
|
$109.56 K
|
| Weighted Average Shares Out Diluted |
$2.67 M
|
$536.29 K
|
$213.46 K
|
$163.38 K
|
$149.55 K
|
$141.47 K
|
$131.52 K
|
$125.31 K
|
$113.44 K
|
$109.56 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
